Study to Assess Efficacy and Safety of Three Oral Doses of Laquinimod
- Study Title
- A Clinical Study in Participants With Huntington's Disease (HD) to Assess Efficacy and Safety of Three Oral Doses of Laquinimod
- Teva Identifier
- TV5600-CNS-20007 | 2014-000418-75
- ClinicalTrials.gov Identifier
- NCT02215616
- Study Status
- Completed
- Trial Condition(s)
- Huntington's Disease
- Interventions
- Drug: Laquinimod | Drug: Placebo
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult
- Age Range
- 21 Years to 55 Years
- Trial Duration
- October 28, 2014 - June 19, 2018
- Phase
- Phase 2
